1Mohr JP, Orgogozo JM, Harrison MJG, et al. Meta-analysis of oral nimodipine trials in acute ischemic stroke [ J ]. Cerebrovasc Dis, 1994, 4(3) : 197 -203.
2Horn J, Limburg M. Calcium antagonists for acute ischemie stroke [J]. Cochrane Database Syst Rev, 2000, (2) : CD001928.
3Davis SM, Lees KR, Albers GW, et al. Seffotel in acute ischemia stroke: possible neurotoxic effects of an NMDA antagonist [ J ]. Stroke, 2000, 31 (2) : 347 - 354.
4Lees KR, Asplund K, Carolei A, et al. Glycine antagonist ( gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomized controlled trial [ J ]. Lancet, 2000, 355: 1949 - 1954.
5Albers GW, Goldstein LB, Hall D, et al. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial [ J ]. JAMA, 2001, 256(21 ) : 2673 -2682.
6Muir KW, Lees KR. Excitatory amino acid antagonists for acute stroke [J]. Cochrane Database Syst Rev, 2003, (3) : CD001244.
7Watanabe T, Tanaka M, Watanabe K, et al. Research and development of the free radical scavenger edaravone as a neuroprotectant [J]. Yakugaku Zasshi, 2004, 124(3) : 99 -111.
8Lees K. R.,Zivin J. A.,Ashwood T. et,郭俊(译).NXY-059治疗急性缺血性卒中[J].世界核心医学期刊文摘（神经病学分册）,2006,2(6):4-4. 被引量：13
9Shuaib A, Lees KR, Lyden P, et al. NXY-059 for the treatment of acute ischemic stroke [J]. N Engl J Med, 2007, 357(6) : 562 -571.
10Bogousslavsky J, Victor SJ, Salinas EO, et al. Fiblast (trafermin) in acute stroke: results of the European-Australian phase Ⅱ/Ⅲ safety and efficacy trial [J]. Cerebrovasc Dis, 2002, 14(3 -4) : 239 -251.
